$120 Million for a Company That Takes the Night Shift for Engineers
Traversal announced a $120 million Series B on November 3 at a $1 billion valuation, co-led by Kleiner Perkins, Redpoint and Khosla. The company builds AI site reliability engineering and says annualized revenue grew 9x this year.
- 01THE START — Traversal was founded in 2023, building AI site reliability engineering.
- 02THE PRODUCT — In September 2026, Incident Workers launched and Alert Workers entered beta.
- 03THE ROUND — On November 3, a $120 million Series B at a $1 billion valuation was announced.
WHAT HAPPENEDWhat Happened
Traversal announced a $120 million Series B on November 3 at a $1 billion valuation. Kleiner Perkins, Redpoint and Khosla co-led the round, with Sequoia, Battery and Amex Ventures participating, bringing total funding to $173 million.
The New York company, founded in 2023, builds AI site reliability engineering. When production systems fail, the platform uses agents plus causal machine learning to find root causes and run diagnostics, aiming to hand off work that once kept engineers up at night triaging incidents.
The product line expanded once in September. Incident Workers went generally available and Alert Workers entered public beta. The company says quarterly customer investigations rose from 513 at the start of the year to nearly 73,000, with annualized revenue up 9x this year.
THE NIGHT SHIFT GOES FIRSTThe Night Shift Gets Handed to Agents First
The hardest part of a production incident is not difficulty but mess. One failure throws off dozens of signals at once, logs, metrics and deployment records all tangled together, and engineers spend most of their time ruling out irrelevant signals before they can locate the real cause.
Traversal's approach starts by building a model of the production world. Telemetry, code, deployment history and organizational knowledge are assembled into a continuously updated graph, and agents look for causal relationships on that graph instead of keyword-matching through logs. Causation versus correlation is the dividing line between this approach and a general-purpose agent.
CLAIMS VS BENCHMARKSCompany Claims and Independent Tests Must Be Kept Apart
The company's own numbers look striking. Root-cause accuracy above 90% on high-impact incidents and an 85% reduction in mean time to recovery for critical incidents. But these figures come from the company's own production statistics, with no independent audit.
An independent control group pours cold water instead. The ORCA-bench study, run with Cornell Tech and Columbia University, shows the best five frontier agents reaching only 25.3% root-cause accuracy on medium-difficulty incidents, falling to 10% on hard tasks, with hallucination rates as high as 40%. The gap between general agents and a specialized platform is exactly what this round is buying.
BUYING THE ENDGAMEA $120 Million Series B Buys the Endgame
Traversal states its endgame plainly. Software that detects problems itself, understands the cause, takes corrective action, verifies the action worked, and prevents recurrence. That is a five-step loop, and only the first steps are working today.
The round's use of funds matches that endgame. Accelerating research on self-driving production systems and expanding research, engineering and go-to-market teams. A $1 billion valuation buys not today's revenue scale but pricing power once the loop closes.
THE SHIFTWhat Changed
SIGNAL JUDGMENT — ANALYSISThe night shift of incident response is being handed to machines
Tokenta Signal's judgment: Traversal's round says one thing. Troubleshooting production systems is turning from labor-intensive work into model-intensive work. The companies that get causal models working first will price the market.
WHAT REMAINS UNCERTAINWhat Remains Uncertain
EVIDENCEEvidence
The original confirms Traversal announced a $120 million Series B on November 3 at a $1 billion valuation, co-led by Kleiner Perkins, Redpoint and Khosla, with the company saying annualized revenue grew 9x this year and root-cause accuracy and recovery-time figures self-reported.
PRIMARY SOURCESPrimary Sources
- Unite.AI: Traversal Raises $120M Series B at $1B Valuation to Expand AI SRE
https://www.unite.ai/traversal-raises-120m-series-b-at-1b-valuation-to-expand-ai-sre/ - Dealroom: Traversal raises $120M at $1B valuation to automate incident response
https://dealroom.co/news/169321-traversal-raises-120m-at-1b-valuation-to-automate-incident-response/
RELATEDRelated Intelligence
- Oklo Posts First Revenue of $1.86M as Q3 Loss Widens to $41.7M, Liquidity Hits $3.13B
- Moderna Swings to $162M Profit as Q3 Revenue Hits $1.31B, Crushing Estimates
- Monster Q3 Sales Hit a Record $2.56B on International Growth, but Margins Squeeze Shares
- BILL Q1 Profit Beats, but an Accounting Change Makes Revenue Look Like a Miss